» Articles » PMID: 23699254

Role of Pore-forming Toxins in Bacterial Infectious Diseases

Overview
Specialty Microbiology
Date 2013 May 24
PMID 23699254
Citations 202
Authors
Affiliations
Soon will be listed here.
Abstract

Pore-forming toxins (PFTs) are the most common bacterial cytotoxic proteins and are required for virulence in a large number of important pathogens, including Streptococcus pneumoniae, group A and B streptococci, Staphylococcus aureus, Escherichia coli, and Mycobacterium tuberculosis. PFTs generally disrupt host cell membranes, but they can have additional effects independent of pore formation. Substantial effort has been devoted to understanding the molecular mechanisms underlying the functions of certain model PFTs. Likewise, specific host pathways mediating survival and immune responses in the face of toxin-mediated cellular damage have been delineated. However, less is known about the overall functions of PFTs during infection in vivo. This review focuses on common themes in the area of PFT biology, with an emphasis on studies addressing the roles of PFTs in in vivo and ex vivo models of colonization or infection. Common functions of PFTs include disruption of epithelial barrier function and evasion of host immune responses, which contribute to bacterial growth and spreading. The widespread nature of PFTs make this group of toxins an attractive target for the development of new virulence-targeted therapies that may have broad activity against human pathogens.

Citing Articles

A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation.

Carrasco-Diaz L, Gallardo A, Volta-Duran E, Virgili A, Paez D, Villaverde A Int J Nanomedicine. 2025; 20:2445-2460.

PMID: 40034221 PMC: 11873025. DOI: 10.2147/IJN.S499192.


A new understanding of Acanthamoeba castellanii: dispelling the role of bacterial pore-forming toxins in cyst formation and amoebicidal actions.

Yabrag A, Ullah N, Baryalai P, Ahmad I, Zlatkov N, Toh E Cell Death Discov. 2025; 11(1):66.

PMID: 39971918 PMC: 11839945. DOI: 10.1038/s41420-025-02345-8.


Pneumolysin-responsive liposomal platform for selective treatment of Streptococcus pneumoniae.

Watt E, Andriescu I, Ho E Drug Deliv Transl Res. 2024; .

PMID: 39285123 DOI: 10.1007/s13346-024-01708-5.


Variations in candidalysin amino acid sequence influence toxicity and host responses.

Wickramasinghe D, Lyon C, Lee S, Hepworth O, Priest E, Maufrais C mBio. 2024; 15(8):e0335123.

PMID: 38953356 PMC: 11323794. DOI: 10.1128/mbio.03351-23.


A High-Homology Region Provides the Possibility of Detecting β-Barrel Pore-Forming Toxins from Various Bacterial Species.

Nagel A, Vetrova O, Rudenko N, Karatovskaya A, Zamyatina A, Andreeva-Kovalevskaya Z Int J Mol Sci. 2024; 25(10).

PMID: 38791367 PMC: 11120785. DOI: 10.3390/ijms25105327.


References
1.
Sugimoto N, Haque A, Horiguchi Y, Matsuda M . Coronary vasoconstriction is the most probable cause of death of rats intoxicated with botulinolysin, a hemolysin produced by Clostridium botulinum. Toxicon. 1995; 33(9):1215-30. DOI: 10.1016/0041-0101(95)93862-o. View

2.
Necchi V, Sommi P, Ricci V, Solcia E . In vivo accumulation of Helicobacter pylori products, NOD1, ubiquitinated proteins and proteasome in a novel cytoplasmic structure. PLoS One. 2010; 5(3):e9716. PMC: 2838800. DOI: 10.1371/journal.pone.0009716. View

3.
Mureithi M, Finn A, Ota M, Zhang Q, Davenport V, Mitchell T . T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease. J Infect Dis. 2009; 200(5):783-93. DOI: 10.1086/605023. View

4.
Songer J . Clostridial enteric diseases of domestic animals. Clin Microbiol Rev. 1996; 9(2):216-34. PMC: 172891. DOI: 10.1128/CMR.9.2.216. View

5.
Kobayashi S, Malachowa N, Whitney A, Braughton K, Gardner D, Long D . Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis. 2011; 204(6):937-41. PMC: 3156927. DOI: 10.1093/infdis/jir441. View